Searched for
THYROCARE RALLY
Corporate actions: HDFC AMC, Thyrocare Technologies shares to trade ex-bonus next week. Check detailsHDFC Asset Management Company and Thyrocare Technologies will trade ex-bonus next week. Record dates are set for November 26 and November 2...- Market Trading Guide: Buy GRSE and Thyrocare Technologies on Monday for up to 12% gainsNifty ended higher after a late rebound driven by financials, pharma, and FMCG, supported by sentiment linked to the NDA’s Bihar victory. T...
- Sensex falls! But these stocks are up over 10% on BSEIn the Nifty 50 index, 17 stocks were trading in the green, while 33 stocks were trading in the red.
- Sensex falls! But these stocks gained over 10% on BSEIn the Nifty 50 index, 4 stocks ended in the green, while 46 stocks closed in the red in today's trade.
- Sensex falls! But these stocks rallied over 15% on BSE in today's tradeIn the Nifty50 index, 4 stocks closed in the green, while 46 stocks ended in the red.
- Thyrocare Technologies shares soar nearly 17% as Q1 results impress D-StreetThyrocare’s pathology and radiology segments’ revenues grew 16% and 15% YoY, respectively. Meanwhile the revenue from partnerships surged 2...
- Sensex falls! But these stocks gained over 10% on BSEIn the Nifty 50 index, 14 stocks ended in the green, while 36 stocks closed in the red in today's trade.
- Thyrocare Tech jumps 10%, crosses 100-DMA first time since Nov 2021At 12.35 pm, the scrip was trading 8.16 per cent higher at Rs 711 over the last day’s closing of Rs 657.35 a piece. The stock has declined ...
- Diagnostic stocks scramble for new growth in India as Covid gains halveSurging healthcare spending and demand for Covid tests led to multifold share-price gains for pathology firms globally during the pandemic.
- Diagnostic chains eye IPO route to raise fundsThe euphoria is aided by a massive spike in the share prices of already listed entities such as Metropolis Healthcare, Dr Lal Pathlabs, Med...
- PharmEasy buyout puts Thyrocare in a different league: AnalystsThyrocare is making efforts to bolster its brand visibility through the opening of regional and zonal reference laboratories and branded co...
- Valuation of diagnostic stocks unsustainable: Sandip Sabharwal"I think the valuation across the board is excessive, be it Metropolis or Dr Lal Path Labs. Thyrocare is slightly less expensive, but it is...
- Reduce Thyrocare Technologies, target price Rs 985: ICICI SecuritiesThyrocare Technologies Ltd., incorporated in the year 2000, is a Mid Cap company (having a market cap of Rs 5627.95 Crore) operating in Hos...
- Travel companies rally, lab & food hitThe news about a potent vaccine from global pharma giant Pfizer, along with Germany’s BioNTech, was a booster for hotel, airline and travel...
- Up to 350% rally YTD: 275 stocks where promoters raised stake in Q2Data shows stocks of 46 per cent of the companies where promoter holding went up have rallied up to 350 per cent since January this year, w...
- Book profit now! After solid rally, red flag goes up on these stocksShares of three key listed diagnostics companies – Thyrocare Technologies, Metropolis Healthcare and Dr Lal Pathlabs – hit their respective...
- Sensex surge! Stocks that gained 10% or moreThe 30-share Sensex closed 600.87 points up at 39574.57 on Tuesday, while the 50-share Nifty index settled 159.05 points up at 11662.4.
- Market Movers: Smallcaps race ahead; NTPC, Thyrocare jump; 66 stocks blink 'sell' signalsHere is a lowdown of what happened in Monday’s trade
- Cash-rich companies rally as traders bet on big dividend payoutsPromoters may have to pay 43 per cent tax on dividends from April 1.
- Diagnostic cos fall on Reliance Life’s proposed entryOn Monday, these three stocks fell between 1 per cent and 3 per cent.
Load More
